We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:
Medicine & public health

Search Results

Showing 1-20 of 104 results

  1. Optic disc drusen: Dystrophic calcification, a potential target for treatment

    Optic disc drusen (ODD) are calcified, acellular bodies, seen in the optic nerve head of up to 2% of the population. Although seldomly affecting...

    Josephine Mejdahl Bentin, Steffen Heegaard, ... Steffen Hamann in Eye
    Article 22 May 2024

  2. Treatment of nonarteritic anterior ischemic optic neuropathy with an endothelin antagonist: ENDOTHELION (ENDOTHELin antagonist receptor in Ischemic Optic Neuropathy)—a multicentre randomised controlled trial protocol

    Background

    Nonarteritic anterior ischemic optic neuropathy (NAAION) is a major cause of blindness in individuals over 50 years of age, with no...

    Christophe Chiquet, Catherine Vignal, ... Jean-Louis Pepin in Trials
    Article Open access 29 October 2022

  3. Risk factors for failure of resolving optic disc pit maculopathy after primary vitrectomy without laser photocoagulation

    Purpose

    To determine factors significantly correlated with the failure of macular reattachment by pars plana vitrectomy (PPV) without laser...

    Masahiko Sano, Akito Hirakata, ... Makoto Inoue in Japanese Journal of Ophthalmology
    Article 09 September 2021

  4. Optic disc drusen: a systematic review

    Background

    Optic disc drusen (ODD) are acellular deposits in the prelaminar optic nerve head. The most accredited theory is that they are secondary to...

    Davide Allegrini, Luca Pagano, ... Mario R. Romano in International Ophthalmology
    Article 07 May 2020

  5. Intravitreal dexamethasone implant for central retinal vein occlusion without macular edema

    Background

    To evaluate the efficacy of an intravitreal dexamethasone (IVD) implant (Ozurdex®) for the treatment of central retinal vein occlusion...

    Eun Young Choi, Hyun Goo Kang, ... Min Kim in BMC Ophthalmology
    Article Open access 17 April 2019

  7. Short-term results of endovascular surgery with tissue plasminogen activator injection for central retinal vein occlusion

    Purpose

    To examine the effects of retinal endovascular surgery (REVS) with tissue plasminogen activator injection into the retinal vein in central...

    Masaaki Ishida, Shinya Abe, ... Atsushi Hayashi in Graefe's Archive for Clinical and Experimental Ophthalmology
    Article 12 August 2017

  8. Effect of oral niacin on central retinal vein occlusion

    Purpose

    Niacin, a treatment for dyslipidemia, is known to induce vasodilation as a secondary effect. Previous instances of patients with chronic...

    Michael W. Gaynon, Yannis M. Paulus, ... Sam E. Mansour in Graefe's Archive for Clinical and Experimental Ophthalmology
    Article 04 February 2017

  9. Comparison between ranibizumab and aflibercept for macular edema associated with central retinal vein occlusion

    Purpose

    We compared the efficacy of bimonthly intravitreal injections of ranibizumab (IVR) with that of bimonthly intravitreal injections of...

    Yoshitsugu Saishin, Yuka Ito, ... Masahito Ohji in Japanese Journal of Ophthalmology
    Article 22 September 2016

  11. Systematic literature review of treatments for management of complications of ischemic central retinal vein occlusion

    Background

    To understand the clinical and economic outcomes of treatments for managing complications of ischemic central retinal vein occlusion...

    Steven E. Bradshaw, Smeet Gala, ... Panos Kefalas in BMC Ophthalmology
    Article Open access 11 July 2016

  12. Anterior chamber depth and angle-closure glaucoma after central retinal vein occlusion

    Background

    The purpose of this study was to report the anterior chamber (AC) depth and the attack of angle-closure glaucoma (ACG) in eyes with the...

    Shiu-Chen Wu, Yung-Sung Lee, ... Shirley H. L. Chang in BMC Ophthalmology
    Article Open access 31 May 2016

  13. Vision-related quality of life in patients receiving intravitreal ranibizumab injections in routine clinical practice: baseline data from the German OCEAN study

    Background

    Vision-related quality of life (vrQoL) is advancing more and more into the focus of interest in ophthalmological clinical research....

    Thomas Bertelmann, Nicolas Feltgen, ... Focke Ziemssen in Health and Quality of Life Outcomes
    Article Open access 20 September 2016

  15. Evaluation of the long-term results of trabectome surgery

    The aim of this study was to investigate the safety and efficacy of ab interno trabeculectomy which is a minimally invasive glaucoma surgery, in the...

    Yildiray Yildirim, Taner Kar, ... Melih Hamdi Unal in International Ophthalmology
    Article 09 February 2016

  17. Update in the Management of Macular Edema Following Retinal Vein Occlusions

    Retinal vein occlusion (RVO) is a common retinal vascular disease classified according to the anatomical location of the occlusion in central (CRVO)...

    Mariana R. Thorell, Raquel Goldhardt in Current Ophthalmology Reports
    Article 10 March 2016

  18. International Society for Therapeutic Ultrasound Conference 2016

    Brian Fowlkes, Pejman Ghanouni, ... Catharina Davies in Journal of Therapeutic Ultrasound
    Article Open access 17 March 2017

  20. Influence of diabetes and diabetes type on anatomic and visual outcomes following central rein vein occlusion

    Purpose

    To determine the influence of diabetes and diabetes type on ocular outcomes following central retinal vein occlusion (CRVO).

    Methods ...
    J G Santiago, S Walia, ... P S Silva in Eye
    Article 14 February 2014
Did you find what you were looking for? Share feedback.